Vaccine Marketing - Innovation and Marketing in the Pharmaceutical Industry - page 414

Parikh RK (2008) Fighting for the reputation of vaccines: lessons from American politics.
Pediatrics 121(3):621-622
Payaprom Y, Bennett P, Alabaster E, Tantipong H (2011) Using the health action process approach
and implementation intentions to increase fl u vaccine uptake in high risk Thai individuals:
a controlled before-after trial. Health Psychol 30(4):492-500
Petrovic K, Burney S, Fletcher J (2011) The relationship of knowledge, health value and health
self-efficacy with men's intentions to receive the human papillomavirus (HPV) vaccine.
J Health Psychol 16(8):1198-1207
Phelps CE (1978) Illness prevention and medical insurance. J Hum Resour 183-207
Philipson T (2000) Economic epidemiology and infectious diseases. In: Culyer AJ, Newhouse JP
(eds) Handbook of health economics, vol 1B. Elsevier, The Netherlands, pp 1761-1799
Poland GA, Jacobson RM (2011) The age-old struggle against the antivaccinationists. N Engl J
Med 364(2):97-99
Porter M (1980) Competitive strategy. Free Press, New York, NY
Prislin R, Dyer JA, Blakely CH, Johnson CD (1998) Immunization status and sociodemographic
characteristics: the mediating role of beliefs, attitudes, and perceived control. Am J Public
Health 88(12):1821
Rand CM, Shone LP, Albertin C, Auinger P, Klein JD, Szilagyi PG (2007) National health care
visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr
Adolesc Med 161(3):252-259
Rao N, Mobius MM, Rosenblat T (2007) Social networks and vaccination decisions. Federal
Reserve Bank of Boston, Working Papers: 07-1
Raude J, Caille-Brillet al, Setbon M (2010) The 2009 pandemic H1N1 infl uenza vaccination in
France: who accepted to receive the vaccine and why? PLoS Curr 2, RRN1188
ResearchInChina (2011) China human vaccine industry report 2010-2011, Beijing http://www.
researchinchina.com/Htmls/Report/2011/6124.html , accessed Jul 4, 2013
Reyna VF (2012) Risk perception and communication in vaccination decisions: a fuzzy-trace
theory approach. Vaccine 30(25):3790-3797
Riedesel J, Rosenthal S, Zimet G, Bernstein D, Huang B, Lan D et al (2005) Attitudes about human
papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol 18(6):391-398
Rivis A, Sheeran P, Armitage CJ (2009) Expanding the affective and normative components of the
theory of planned behavior: a meta-analysis of anticipated affect and moral norms. J Appl Soc
Psychol 39(12):2985-3019
Roehm ML, Tybout AM (2006) When will a brand scandal spill over, and how should competitors
respond? J Mark Res 43(3):366-373
Roese NJ (1997) Counterfactual thinking. Psychol Bull 121(1):133-148
Rogers RW (1975) A protection motivation theory of fear appeals and attitude change. J Psychol
91:93-114
Rogers RW (1983) Cognitive and physiological processes in fear appraisals and attitude change: a
revised theory of protection motivation. In: Cacioppo JT, Petty RE (eds) Social psychology: a
source topic. Guildford, New York, NY, pp 153-176
Rosenbom KA (2010) Developments in UNICEF vaccine procurement. Global Immunization
Meeting. http://www.who.int/immunization_delivery/systems_policy/Vaccine_supply_and_
pricing.pdf . Accessed 22 Aug 2011
Rosenstock IM (1974) Historical origins of the health belief model. Health Educ Monogr 2:328-335
Rosenthal E (2008) Drug makers' push leads to cancer vaccines' fast rise. The New York Times,
20 Aug
Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD (2011) Predictors of HPV
vaccine uptake among women aged 19-26: importance of a physician's recommendation.
Vaccine 29(5):890-895
Rothman SM, Rothman DJ (2009) Marketing HPV vaccine: implications for adolescent health and
medical professionalism. JAMA 302(7):781-786
Roughead EE, Gilbert AL, Vitry AI (2008) The Australian funding debate on quadrivalent HPV
vaccine: a case study for the national pharmaceutical policy. Health Policy 88(2):250-257